Neochord, Inc.

Neochord, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company’s flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.

Company Details

Employees
20
Founded
-
Address
Maple Grove, Mn, Us
Phone
952-698-7800
Email
in****@****ord.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Maple Grove, MN
Looking for a particular Neochord, Inc. employee's phone or email?

Neochord, Inc. Questions

News

NeoChord Announces Positive 1-year Follow-Up Data with - GlobeNewswire

NeoChord Announces Positive 1-year Follow-Up Data with GlobeNewswire

Posterior leaflet reconstruction in mitral valve repair: Does resect versus respect strategy matter? - ScienceDirect.com

Posterior leaflet reconstruction in mitral valve repair: Does resect versus respect strategy matter? ScienceDirect.com

Echocardiographic and clinical outcomes following beating heart NeoChord DS1000 mitral valve repair: a single centre case series - Frontiers

Echocardiographic and clinical outcomes following beating heart NeoChord DS1000 mitral valve repair: a single centre case series Frontiers

NeoChord Receives FDA Approval to Begin Clinical Trial of DS1000 System - Diagnostic and Interventional Cardiology

NeoChord Receives FDA Approval to Begin Clinical Trial of DS1000 System Diagnostic and Interventional Cardiology

NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation - BioSpace

NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation BioSpace

First-in-Human Transseptal Transcatheter Mitral Chordal Repair: - JACC Journals

First-in-Human Transseptal Transcatheter Mitral Chordal Repair: JACC Journals

10 Hot Devices We Can't Get in the U.S.—NeoChord DS1000 - Medical Device and Diagnostic industry

10 Hot Devices We Can't Get in the U.S.—NeoChord DS1000 Medical Device and Diagnostic industry

Mitral valve repair company NeoChord has a new CEO - MassDevice

Mitral valve repair company NeoChord has a new CEO MassDevice

Heart Valve Repair Co. NeoChord Closes $25M Series D - Twin Cities Business

Heart Valve Repair Co. NeoChord Closes $25M Series D Twin Cities Business

Med-tech company NeoChord raises $25M for heart device - The Business Journals

Med-tech company NeoChord raises $25M for heart device The Business Journals

Microinvasive mitral valve repair with transapical mitral neochordae implantation - Frontiers

Microinvasive mitral valve repair with transapical mitral neochordae implantation Frontiers

NeoChord Receives CE Mark for DS1000 Mitral Valve Repair Device - Diagnostic and Interventional Cardiology

NeoChord Receives CE Mark for DS1000 Mitral Valve Repair Device Diagnostic and Interventional Cardiology

Computer simulations of transapical mitral valve repair with neochordae implantation: Clinical implications - ScienceDirect.com

Computer simulations of transapical mitral valve repair with neochordae implantation: Clinical implications ScienceDirect.com

NeoChord raises $25m in Series D - MassDevice

NeoChord raises $25m in Series D MassDevice

Heart-string maker NeoChord closes $20M round of funding to pursue approval - The Business Journals

Heart-string maker NeoChord closes $20M round of funding to pursue approval The Business Journals

Case report: Recurrent severe mitral regurgitation due to ruptured artificial chords after transapical Neochord mitral valve repair - Frontiers

Case report: Recurrent severe mitral regurgitation due to ruptured artificial chords after transapical Neochord mitral valve repair Frontiers

First Pennsylvania Patient Enrolled in RECHORD Trial of Neochord DS1000 System - Diagnostic and Interventional Cardiology

First Pennsylvania Patient Enrolled in RECHORD Trial of Neochord DS1000 System Diagnostic and Interventional Cardiology

First in human neochordae retensioning for recurrence of mitral regurgitation after neochord procedure - Frontiers

First in human neochordae retensioning for recurrence of mitral regurgitation after neochord procedure Frontiers

First Patient Treated in U.S. Trial of NeoChord DS1000 System - Diagnostic and Interventional Cardiology

First Patient Treated in U.S. Trial of NeoChord DS1000 System Diagnostic and Interventional Cardiology

Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej - Termedia

Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej Termedia

Top Neochord, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant